Health

Study: Gut Hormone Could Potentially Accelerate Fat Burning

Published NOV 12 2025

Story

Image credit: Unsplash

The Facts

Researchers at the State University of Campinas have discovered that FGF19, a hormone produced in the small intestine, acts on the hypothalamus to stimulate thermogenic adipocyte activity and increase energy expenditure in obese mice.
American Physiological Society Journal
Agência FAPESP
The study, published in the American Journal of Physiology – Endocrinology and Metabolism, found that central FGF19 signaling improved energy homeostasis by activating the sympathetic nervous system and stimulating adipose tissue thermogenesis, thereby increasing heat production by fat cells.
Report.az
Drug Target Review
FGF19 administration in obese mice resulted in decreased body weight gain, improved glucose-insulin homeostasis, reduced peripheral inflammation and enhanced cold tolerance through increased activity of brown and white adipose tissues.
American Physiological Society Journal
SciTech Daily
When sympathetic nervous system activity was experimentally inhibited, the beneficial effects of FGF19 on thermogenesis and energy expenditure were completely abolished — reportedly demonstrating the critical role of neural pathways.
Drug Target Review
EurekAlert!
Cold exposure increased FGF19 receptor expression specifically in the hypothalamus, suggesting an adaptive role for this hormone in thermoregulation and energy balance.
Report.az
Agência FAPESP
According to researchers, the discovery could lead to new obesity and diabetes treatments similar to existing therapies such as Ozempic, which uses compounds that mimic naturally occurring hormones to regulate metabolism and body weight.
EurekAlert!
SciTech Daily

Sources Split

LEFT

CENTER

RIGHT

ESTAB
CRIT

CENTER

PRO
ESTAB

The Spin

Techno-optimist narrative

FGF19 is a revolutionary breakthrough in obesity treatment that goes beyond appetite suppression to actually reprogram how the body burns energy. This gut hormone flips a biological switch, shifting from fat storage to fat burning by boosting metabolism at the brain's control center. Unlike current treatments that just reduce hunger, FGF19 forces the body to spend more energy and could lead to safer, more effective therapies for over one billion obese people worldwide.

Curiosity Science on Instagram

Techno-skeptic narrative

While FGF19 shows promise, the research remains in early experimental stages with significant limitations that temper excitement. The hormone required direct injection into the mouse brains to show effects, and the benefits completely disappeared when certain nervous system pathways were blocked. Current obesity projections show 1.5 billion affected people by 2030, but translating mouse brain injection results to practical human treatments faces enormous scientific and safety hurdles.

Medicalxpress

Cynical narrative

The obesity-crisis narrative often feeds on bias, profit and fear. Media headlines exaggerate risks, fueling anxiety and stigma. Industries profit from diet products and weight-loss programs, while society blames individuals rather than systems. Beneath the panic lies a complex truth — health cannot be reduced to numbers or appearances alone. Obesity isn't merely an individual issue — it requires a collective, society-wide effort to address its root causes.